Development Status

iPSC Regenerative Medicine

【Ophthalmology Area】

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCR011 Wet AMD Japan
Joint development with Sumitomo Dainippon Pharma
Undergoing preparation for clinical trial
Development Code Indication Market Pre-clinical test Phase I Trial Phase II Trial Phase III Trial Apply-approve On the Market Progress Status
HLCR012 Dry AMD US
EU
CRADA with NEI

【Liver Disease】

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCL041 Metabolic Liver Disease Japan
Joint research with Yokohama City University

Somatic Stem Cell Regenerative Medicine

Development Code Indication Market Pre-clinical test Apply-approve On the Market Progress Status
HLCM051 Ischemic Stroke Japan
Clinical trial (TREASURE study) ongoing
HLCM051 ARDS Japan
Clinical trial (ONE-BRIDGE study) ongoing